Pfizer cancer med Inlyta wins EU approval; Sanofi, Impax settle patent fight over Genzyme drugs;

 @FiercePharma: Here's more on the 'gutter oil' scandal in China, allegedly used to make antibiotics. Report | Follow @FiercePharma

> Pfizer ($PFE) won European approval for its kidney cancer drug Inlyta as a second-line treatment for a type of advanced kidney cancer. Report

> Impax Laboratories ($IPXL) settled a patent dispute with Sanofi ($SNY) over generic versions of kidney drugs Renvela and Renagel, winning licenses to sell generic versions in 2014. Report

> In the last two months, FDA has lifted bans on the manufacturing faciltiies of several Indian pharma companies, including Sun Pharma, Dr. Reddy's Laboratories and Claris Lifesciences. Report

> Germany's Grunenthal apologized to victims of thalidomide, a drug withdrawn more than 50 years ago after it was found to cause severe birth defects. Report

> The Competition Commission of India is investigating possible "cartelization" of several domestic industries, including pharmaceuticals. Report

Medical Device News

 @FierceMedDev: Watch out, Medtronic, BSX and the rest, researchers have developed a pacemaker that fits on the head of a pin. Story | Follow @FierceMedDev

 @MarkHFierce: So, non-invasive Dx imaging costs for Medicare Part B actually went down from 2006-10. Not so pricey after all. Release | Follow @MarkHFierce

 @DamianFierce: Philips Healthcare's Respironics is conducting its second ventilator recall in as many months. Story | Follow @DamianFierce

> ConvaTec snags catheter maker for $321M. News

> Medicare Dx costs enjoy steady drop. Item

> I-Flow recalls infusion pumps over deadly flaw. News

Biotech News

 @FierceBiotech: Penn grabs Agios deal, settling high-profile IP theft claim. Report | Follow @FierceBiotech

 @JohnCFierce: Offbeat: Pulmatrix's Robert Connelly leaves to helm WikiCell, creating "delicious" food packaging; The startup has Flagship, Polaris backing. Release | Follow @JohnCFierce

> Merck KGaA adds big job cuts, $316M R&D makeover to restructuring plan. More

> Valeant scoops up Medicis' dermatology portfolio in $2.6B buyout. News

> Medivation wins groundbreaking FDA OK for blockbuster prostate cancer drug. Article

Pharma Manufacturing News

> 2 Merck KGaA production facilities whacked in cuts. Article

> Dangers aside, drugmakers can't live without Chinese APIs. Story

Biotech IT News

> Merck Serono bioinformatics head starts new company. Item

> PerkinElmer partners with MGH on informatics system for cancer research. Article

> Video game players take on deadly sepsis for U.S. military. Story

> CLC bio buys molecular docking software company Molegro. News

> Tech startup waltzes with wireless giant in Africa to expand mobile anti-drug counterfeiting system. More

Biotech Research News

> Worm stem cells carry tissue regeneration clues. Report

> Johns Hopkins scientists produce protein that helps track tumors. Item

> Roche/Genentech drug beats back treatment-resistant breast cancer cells. Article

> Cleveland Clinic's Alzheimer's drug makes strong preclinical debut. More

> Gene therapy rebuilds sense of smell in mice. Story

CRO News

> U.K.'s NHS considers commercial services; Big Pharma intrigued. Report

> Hospira drops $200M on Indian API plant. News

> Indian regulator wants to expand its ranks. More

> Charles River snaps up Accugenix for $17M. Story

And Finally... Some 10,000 Yosemite campers may be at risk of hantavirus, the CDC said. Report